Liquidia (LQDA) Revenue (2020 - 2026)
Liquidia (LQDA) posted Revenue of $171.7 million for Q2 2026, up 29.21% on a QoQ basis from $132.9 million in Q1 2026, and up 1842.73% year-over-year from $8.8 million in Q2 2025.
Analysis
Liquidia (LQDA) Revenue (2020 - 2026) Analysis & Trends
Liquidia has reported Revenue for 7 years, with the latest figure at $171.7 million in Q2 2026.
- On a quarterly basis, Revenue rose 1842.73% year-over-year to $171.7 million in Q2 2026; TTM through Jun 2026 was $450.9 million, a 2233.65% increase from a year earlier, with the FY2025 full-year figure at $158.3 million, up 1031.18% from the prior year.
- Revenue was $171.7 million for Q2 2026 at Liquidia, up from $132.9 million in the prior quarter.
- The five-year high for Revenue was $171.7 million in Q2 2026, with the low at $2.9 million in Q4 2024.
- Average Revenue over 5 years is $28.3 million, with a median of $4.5 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Revenue plunged 35.62% in 2024, then jumped 4158.49% in 2026.
- Over 5 years, Revenue stood at $5.4 million in 2022, then fell by 15.47% to $4.5 million in 2023, then slumped by 35.62% to $2.9 million in 2024, then surged by 3054.65% to $92.0 million in 2025, then jumped by 86.57% to $171.7 million in 2026.
- The last three Revenue figures came in at $171.7 million (Q2 2026), $132.9 million (Q1 2026), and $92.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 15.03 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 13.48 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 1.67 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 783.30 Mn |
| 10 | Liquidia | 6.09 Bn | 5.81 Bn | 160.92 Mn | 171.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171.68 Mn |
| Mar 31, 2026 | 132.87 Mn |
| Dec 31, 2025 | 92.02 Mn |
| Sep 30, 2025 | 54.34 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 3.66 Mn |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 3.92 Mn |
| Mar 31, 2022 | 3.49 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.18 Mn |